Clinical Trial Update: Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis [NA]

View source ↗

Summary

The clinical trial evaluating quantitative imaging and proton spectroscopy in multiple sclerosis sponsored by NYU Langone Health has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: NYU Langone Health | Conditions: Multiple Sclerosis | NA | Status: TERMINATED